Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women

Ting Yuan David Cheng, Xiaoling Song, Shirley A.A. Beresford, Gloria Y.F. Ho, Karen C. Johnson, Mridul Datta, Rowan T. Chlebowski, Jean Wactawski-Wende, Lihong Qi, Marian L. Neuhouser

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Purpose: Vitamin D has been implicated in lowering lung cancer risk, but serological data on the association among never-smoking women are limited. We report results examining the association of serum 25-hydroxyvitamin D [25(OH)D] concentrations with lung cancer risk among female never smokers. We also examined whether the association was modified by vitamin D supplementation and serum vitamin A concentrations. Methods: In the Women’s Health Initiative, including the calcium/vitamin D (CaD) Trial, we selected 298 incident cases [191 non-small cell lung cancer (NSCLC) including 170 adenocarcinoma] and 298 matched controls of never smokers. Baseline serum 25(OH)D was assayed by a chemiluminescent method. Logistic regression was used to estimate odds ratios (ORs) for quartiles and predefined clinical cutoffs of serum 25(OH)D concentrations. Results: Comparing quartiles 4 versus 1 of serum 25(OH)D concentrations, ORs were 1.06 [95% confidence interval (CI) 0.61–1.84] for all lung cancer, 0.94 (95% CI 0.52–1.69) for NSCLC, and 0.91 (95% CI 0.49–1.68) for adenocarcinoma. Comparing serum 25(OH)D ≥ 75 (high) versus <30 nmol/L (deficient), ORs were 0.76 (95% CI 0.31–1.84) for all lung cancer, 0.71 (95% CI 0.27–1.86) for NSCLC, and 0.81 (95% CI 0.31–2.14) for adenocarcinoma. There is suggestive evidence that CaD supplementation (1 g calcium + 400 IU D3/day) and a high level of circulating vitamin A may modify the associations of 25(OH)D with lung cancer overall and subtypes (p interaction <0.10). Conclusions: In this group of never-smoking postmenopausal women, the results did not support the hypothesis of an association between serum 25(OH)D and lung cancer risk.

Original languageEnglish (US)
Pages (from-to)1053-1063
Number of pages11
JournalCancer Causes and Control
Volume28
Issue number10
DOIs
StatePublished - Oct 1 2017

Keywords

  • 25-Hydroxyvitamin D
  • Histology
  • Lung cancer
  • Never smokers
  • Postmenopausal women

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women'. Together they form a unique fingerprint.

  • Cite this

    Cheng, T. Y. D., Song, X., Beresford, S. A. A., Ho, G. Y. F., Johnson, K. C., Datta, M., Chlebowski, R. T., Wactawski-Wende, J., Qi, L., & Neuhouser, M. L. (2017). Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women. Cancer Causes and Control, 28(10), 1053-1063. https://doi.org/10.1007/s10552-017-0956-1